Medicine & Life Sciences
Streptococcus pneumoniae
100%
Biofilms
76%
Milk Proteins
35%
Anti-Bacterial Agents
35%
Pharmaceutical Preparations
30%
Human Milk
30%
Bacteria
28%
Infections
24%
Streptococcus pyogenes
24%
Injections
23%
Nasopharynx
21%
Endocarditis
19%
Lipids
18%
Bacteremia
18%
human HAMLET complex
17%
In Vitro Techniques
17%
Staphylococcus aureus
17%
Streptococcus
16%
pneumococcal surface protein A
15%
Pneumococcal Infections
14%
Fomites
14%
Opioid Analgesics
13%
Genetic Transformation
13%
Influenza A virus
13%
Retention in Care
13%
Burkholderia
13%
Pre-Exposure Prophylaxis
12%
Virulence
11%
Anti-Infective Agents
11%
Growth
11%
Intracellular Membranes
11%
Coronavirus
11%
Saccharomycetales
10%
Methicillin
10%
Outpatients
10%
Orthomyxoviridae
10%
Patient Discharge
10%
Epithelial Cells
9%
Pandemics
9%
Fluorescent Dyes
9%
Glycolysis
9%
Superoxides
8%
American Heart Association
8%
Sexually Transmitted Diseases
8%
Virus Diseases
8%
Patient Care
8%
Genetic Recombination
8%
Transcriptome
8%
Mental Competency
8%
Cost-Benefit Analysis
7%
Agriculture & Biology
Streptococcus pneumoniae
32%
biofilm
32%
antibiotics
16%
human milk proteins
14%
fomites
14%
nasopharynx
14%
Streptococcus pyogenes
14%
Influenza A virus
11%
methicillin
11%
lactalbumin
10%
Orthomyxoviridae
10%
anti-infective agents
10%
surface proteins
10%
Staphylococcus aureus
9%
Streptococcus
9%
infection
8%
neoplasm cells
8%
pathogens
8%
transcriptome
7%
epithelial cells
7%
bacteria
6%
adjuvants
6%
lipids
5%